|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 在在 ERCP 的针刀 fistulotomy 和标准管子之间的比较显示文摘 AIM:To compare the rates of success and complications of two different methods of access into the common bile duct(CBD).METHODS:Between October 2007 and November 2008,173 consecutive patients(71 men,102 women,mean age 68.6 years) requiring endoscopic retrograde cannulation of the papilla and endoscopic treatment were studied.In the first 88 patients CBD cannulation was performed through supra-papillary fistulotomy(group F);in the following 85 patients standard cannulation was performed through the Oddi sphincter(group S).Indications for the procedure were:choledocholithiasis,biliary obstruction,postoperative leak,sclerosing cholangitis,and Mirizzi’s syndrome.RESULTS:Deep CBD cannulation was successful in 85/88 patients(96.5%) in group F vs 60/85 patients(70.6%) in group S(P < 0.0001).The remaining 25 group S patients in whom cannulation failed were shifted to fistulotomy.Fistulotomy was successful in 21/25 patients(84%).As for complications,hyperamilasemia occurred in 7(7.9%) group F patients vs 7(8.2%)group S patients(P = NS);mild pancreatitis in 1(1.1%) group F patient vs 5(5.8%) group S patients(P = NS);bleeding in 3(3.4%) group F patients vs 3(3.5%) group S patients(P = NS).CONCLUSION:Needle-knife fistulotomy should represent either the first approach to therapeutic cannulation or rescue therapy after unsuccessful standard cannulation. | Mohammad Ayoubi Gianni Sansoè Nicola Leone Francesca Castellino | 2012 | World Journal of Gastrointestinal Endoscopy2012，4，9： | 5 |
| 2 | Arterial structure and function in inflammatory bowel disease显示文摘Inflammatory bowel disease(IBD) is the result of a combination of environmental,genetic and immunologic factors that trigger an uncontrolled immune response within the intestine,which results in inflammation among genetically predisposed individuals. Several studies have reported that the prevalence of classic cardiovascular risk factors is lower among subjects with IBD than in the general population,including obesity,dyslipidaemia,diabetes and hypertension. Therefore,given the risk profile of IBD subjects,the expected cardiovascular morbidity and mortality should be lower in these patients than in the general population. However,this is not the case because the standardized mortality ratio is not reduced and the risk of coronary heart disease is increased in patients with IBD. It is reasonable to hypothesize that other factors not considered in the classical stratification of cardiovascular risk may be involved in these subjects. Therefore,IBD may be a useful model with which to evaluate the effects of chronic low-grade inflammation in the development of cardiovascular diseases. Arterial stiffness is both a marker of subclinical target organ damage and a cardiovascular risk factor. In diseases characterized by chronic systemic inflammation,there is evidence that the inflammation affects arterial properties and induces both endothelial dysfunction and arterial stiffening. It has been reported that decreasing inflammation viaanti tumor necrosis factor alpha therapy decreases arterial stiffness and restores endothelial function in patients with chronic inflammatory disorders. Consistent with these results,several recent studies have been conducted to determine whether arterial properties are altered among patients with IBD. In this review,we discuss the evidence pertaining to arterial structure and function and present the available data regarding arterial stiffness and endothelial function in patients with IBD. | Luca Zanoli Stefania Rastelli Gaetano Inserra Pietro Castellino | 2015 | World Journal of Gastroenterology2015，21，40： | 3 |
| 3 | Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome显示文摘 | Sergio Neri Davide Pulvirenti Mariano Malaguarnera Bruno M. Cosimo Gaetano Bertino Luca Ignaccolo Sebasiano Siringo Pietro Castellino | 2008 | Digestive Diseases and Sciences2008，，3： | 2 |
| 4 | Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs显示文摘 | Luca Zanoli Stefania Rastelli Gaetano Inserra Paolo Lentini Enrico Valvo Emanuela Calcagno Pierre Boutouyrie Stephane Laurent Pietro Castellino | 2014 | Atherosclerosis2014，，2： | 2 |
| 5 | Multicentric reticulhistiocytosis 显示文摘 | Trotta F Castellino G Monaco AL | 2004 | Best Pract Res Clin Rheumatol2004，18，5： | 1 |
| 6 | Hodgkin disease:practical concepts for the diagnostic radiologist显示文摘 | Castellino RA | 1986 | Radiology1986，159，： | 1 |
| 7 | Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents 显示文摘 | Vivenza D Rapa A Castellino N | 2004 | Eur J Endoerinol2004，151，1： | 1 |
| 8 | Receptor-mediated up take of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways显示文摘 | Castellino F Boucher PE Eichelberg K | 2000 | J Exp Med2000，191，11： | 1 |
| 9 | NMDA-receptor antagonist requirements in conantokin-G显示文摘 | Blandl T Prorok M Castellino FJ | 1998 | FEBS Lett1998，435，23： | 1 |
| 10 | Primary amyloidosis of the renal pelvis显示文摘 | Gardner K D Jr Castellino R A Kempson R | 1971 | N Engl J Med1971，284，： | 1 |
| 11 | Baseline serum concentrations of TRAIL in early rheumatoid arthritis : relationship with response to disease-modifying antirheumatic drugs 显示文摘 | Secchiero P Corallini F Castellino G | 2010 | J Rheumatol2010，37，7： | 1 |
| 12 | Systemic lupus erythematosus 显示文摘 | Ruiz-lrastorza G Khamashta MA Castellino G | 2001 | Lancet2001，357，9261： | 1 |
| 13 | Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D显示文摘 | Castellino RC De Bortoli M Lu X et al | 2008 | J Neurooncol2008，86，3： | 1 |
| 14 | 显示文摘 | Grella DK Castellino FJ | 1997 | Blood1997，89，： | 1 |
| 15 | Recent advances and perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus显示文摘 | Govoi M Castellino G Padovan M | 2004 | Lupus2004，13，3： | 1 |
| 16 | 查看详情显示文摘 | Castellino V Acosta E Cheng Y L | | 0，，03： | 1 |
| 17 | Multicentric reticulohistiocytosis 显示文摘 | Trotta F Castellino G Lo MA | 2004 | Best Pract Res ClinRheumatol2004，18，5： | 1 |
| 18 | Optimizing clinical monitoring of central nervous system involvement in SLE显示文摘 | Castellino G Govoni M Giacuzzo S | 2008 | Autoimmun Rev2008，7，4： | 1 |
| 19 | The kringle domains of human plasminogen显示文摘 | Castellino FJ McCance SG | 1997 | Ciba Found Symp1997，212，： | 1 |
| 20 | Effect of Renal Artery Stenting on Left Ventricular Mass: A Randomized Clinical Trial显示文摘 | Carmelita Marcantoni Luca Zanoli Stefania Rastelli Giovanni Tripepi Massimo Matalone Sarah Mangiafico Davide Capodanno Salvatore Scandura Domenico Di Landro Corrado Tamburino Carmine Zoccali Pietro Castellino | 2012 | American Journal of Kidney Diseases2012，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员